Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Exclusion Criteria

• •Blockage in the bladder or kidneys
• •Untreated or uncontrolled brain metastases. Treated brain metastases are permitted provided they are neurologically stable
• •Symptomatic, or clinical or radiologic findings indicative of impending cord compression.
• •History of myelodysplastic syndrome (MDS), treatment-related acute myeloid leukaemia or features suggestive of MDS/acute myeloid leukaemia.
• •A known additional malignancy that has required active treatment within the past two years before start of study treatment, except for adequately treated basal or squamous cell carcinoma of the skin, or carcinoma in situ that has undergone curative therapy